Our analysis indicated that RPAP2 expression in HCC and brain lower‐grade glioma was the most significantly associated with patient prognosis (p < 0.0001, Figure 1A; Figure S1A, Supporting Information). This evidence concerns the gene RPAP2 and central nervous system cancer.